|
Q1 FY2027
As of Aug 29, 2026
|
Q4 FY2026
As of May 30, 2026
|
Q3 FY2026
As of Feb 28, 2026
|
Q2 FY2026
As of Nov 29, 2025
|
Q1 FY2026
As of Aug 30, 2025
|
Q4 FY2025
As of May 31, 2025
|
Q3 FY2025
As of Mar 1, 2025
|
Q2 FY2025
As of Nov 30, 2024
|
Q1 FY2025
As of Aug 31, 2024
|
Q4 FY2024
As of Jun 1, 2024
|
Q3 FY2024
As of Mar 2, 2024
|
Q2 FY2024
As of Dec 2, 2023
|
Q1 FY2024
As of Sep 2, 2023
|
Q4 FY2023
As of Jun 3, 2023
|
Q3 FY2023
As of Feb 25, 2023
|
Q2 FY2023
As of Nov 26, 2022
|
Q1 FY2023
As of Aug 27, 2022
|
Q4 FY2022
As of May 28, 2022
|
Q3 FY2022
As of Feb 26, 2022
|
Q2 FY2022
As of Nov 27, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities available-for-sale | ||||||||||||||||||||
| Trade and other receivables, net | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total receivables, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant & equipment, net | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Accrued wages and benefits | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock ($0.01 par value) - authorized 120,000 shares, issued 75,061 shares | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Class A Convertible Common Stock | ||||||||||||||||||||
| Total common stock ($0.01 par value) - authorized 120,000 shares, issued 75,061 shares | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Common stock in treasury at cost - 28,145 shares at August 29, 2026 and 28,080 shares at May 30, 2026 | ||||||||||||||||||||
| Total Cal-Maine Foods, Inc. stockholders' equity | ||||||||||||||||||||
| Noncontrolling interest in consolidated entity | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
